Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. (Q38052634)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

0 references

Helicobacter pylori infectious disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Barry Marshall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

H M Windsor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

W Lu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

C Conway

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

T T Perkins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F Thirriot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

16 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1076-1083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

15 February 2020

cites work

1 reference

Epidemiology of gastric cancer in Japan

21 January 2018

1 reference

The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention

21 January 2018

1 reference

Epidemiology of Helicobacter pylori infection

21 January 2018

1 reference

Helicobacter pylori: a poor man's gut pathogen?

21 January 2018

1 reference

Significant differences in the use of healthcare resources of native-born and foreign born in Spain

21 January 2018

1 reference

Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne

21 January 2018

1 reference

Helicobacter pylori infection in the Australian community: current prevalence and lack of association with ABO blood groups

21 January 2018

1 reference

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

21 January 2018

1 reference

High level of antimicrobial resistance in French Helicobacter pylori isolates

21 January 2018

1 reference

Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.

21 January 2018

1 reference

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

21 January 2018

1 reference

Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

21 January 2018

1 reference

Methodology and transport medium for collection of Helicobacter pylori on a string test in remote locations

21 January 2018

1 reference

Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin.

21 January 2018

1 reference

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

21 January 2018

1 reference

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.

21 January 2018

1 reference

Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium

21 January 2018

1 reference

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

21 January 2018

1 reference

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

21 January 2018

1 reference

Cure rate of high dose omeprazole and amoxicillin therapy for treatment-resistant Helicobacter pylori infection

21 January 2018

1 reference

Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures

21 January 2018

1 reference

Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease

21 January 2018

1 reference

Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

21 January 2018

1 reference

Potential role of cysteine and methionine in the protection against hormonal imbalance and mutagenicity induced by furazolidone in female rats

21 January 2018

1 reference

Furazolidone induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in human hepatoma G2 cells

21 January 2018

1 reference

Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods

21 January 2018

1 reference

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

21 January 2018

1 reference

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

21 January 2018

1 reference

Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori

21 January 2018

1 reference

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.

21 January 2018

1 reference

Helicobacter pylori resistance to rifabutin in the last 7 years.

21 January 2018

1 reference

Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan

21 January 2018

1 reference

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

21 January 2018

1 reference

Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials

21 January 2018

1 reference

Helicobacter pylori "rescue" therapy after failure of two eradication treatments.

21 January 2018

1 reference

Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK.

21 January 2018

1 reference

Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance

21 January 2018

1 reference

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Efficacy of ciprofloxacin in the eradication of Helicobacter pylori

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Treatment of Helicobacter pylori

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Clostridium difficile colitis: an increasing hospital-acquired illness

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/APT.12089

Identifiers

DOI

10.1111/APT.12089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23072648%20AND%20SRC:MED&resulttype=core&format=json